“In one of the most significant victories for public health policy, the Australian High Court upheld the Tobacco Plain Packaging Act, which effectively removes the last form of advertising available to the tobacco industry in the country — logos on cigarette packs,” Cynthia Lewis, a senior program officer for the tobacco initiative at the Bill & Melinda Gates Foundation, writes in the foundation’s “Impatient Optimists” blog. “After a multi-million dollar legal battle, the Government of Australia effectively defended its right to legislate to protect the health of its citizens,” she continues, adding, “While the battle is not yet over — Australia still faces two additional cases with Philip Morris Asia and the World Trade Organization — [Wednesday's] victory establishes an important precedent for plain packaging, and encourages those who seek to implement it elsewhere” (8/15).
Non Communicable Disease/Chronic Disease
“Two fifths of men in developing countries still smoke or use tobacco, and women are increasingly starting to smoke at younger ages, according to a large international study which found ‘alarming patterns’ of tobacco use,” Reuters reports (Kelland, 8/17). The study, published Friday in the Lancet, “covered enough representative samples to estimate tobacco use among three billion people” and “‘demonstrates an urgent need for policy change in low- and middle-income countries,’ said lead researcher Gary Giovino,” according to CNN (Levs, 8/17). “‘Although 1.1 billion people have been covered by the adoption of the most effective tobacco control policies since 2008, 83 percent of the world’s population are not covered by two or more of these policies,’ said [Giovino],” Reuters adds (8/17).
“Australia’s highest court Wednesday rejected a challenge from big tobacco companies to tough new plain-packaging laws due to come into effect later this year, in a legal battle closely watched around the world,” the Wall Street Journal reports, adding, “The ruling is a major blow for global tobacco giants that had been seeking to stop Australia implementing the new laws, fearing the move would set a precedent for other countries to follow” (Curran, 8/14). “Tobacco companies British American Tobacco, Britain’s Imperial Tobacco, Philip Morris and Japan Tobacco challenged the laws in Australia’s high court, claiming the rules were unconstitutional because they effectively extinguished the companies’ intellectual property rights,” according to the Guardian (8/15). “The law, approved by Parliament last year, requires cigarettes to be sold in drab dark packaging starting in December, without logos but featuring graphic images of smoking-related diseases,” the Washington Post writes, adding, “Brand names can still be used, but only in a standard font, size and position” (Hume, 8/15).
One Blog Examines GAVI Alliance's Efforts To Accelerate Introduction Of Hepatitis B Vaccines In Developing Countries
“I am looking forward to participating in the 2012 World Cancer Leaders’ Summit, to be held in Montreal, Canada on August 27,” GAVI Alliance Deputy CEO Helen Evans writes in this post in the One Blog. “This will be an opportunity to take stock of where the world is with regards to cancer prevention and treatment and to learn more about action to address the existing challenges to eliminating cancer as a life-threatening disease for future generations,” she writes, and discusses GAVI’s efforts to “accelerat[e] the introduction of hepatitis B vaccines in developing countries since 2000,” noting “GAVI has helped prevent an estimated 3.7 million deaths from liver cancer (caused by hepatitis B)” (8/21).
The Associated Press/Seattle Times reports on a “mysterious epidemic [that] is devastating the Pacific Coast of Central America, killing more than 24,000 people in El Salvador and Nicaragua since 2000 and striking thousands of others with chronic kidney disease at rates unseen virtually anywhere else.” The news service provides statistics regarding kidney disease in various Central American countries, quotes a number of experts regarding potential causes of the disease and notes, “While some of the rising numbers may be from better record-keeping, scientists believe they are facing something deadly and previously unknown to medicine.”
New York Mayor Michael Bloomberg on Thursday announced his charitable foundation will “spend $220 million over the next four years to discourage tobacco use in developing countries, as he seeks to promote strategies around the world that curbed smoking in his city,” the Wall Street Journal reports (McKay, 3/21). Bloomberg announced “the new funding for Bloomberg Philanthropies on Thursday at the 15th World Conference on Tobacco or Health in Singapore,” Reuters writes, noting “[t]he commitment takes the foundation’s total pledge to the cause to almost $600 million” (Begley et al., 3/22).
IPS Reports On Research Study Examining Knowledge, Beliefs Of Cervical Cancer Among Argentinian Women
Inter Press Service reports on a research study conducted in Argentina that “explored women’s knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies.” The news service writes, “Although there are now effective tools to prevent cervical cancer, and vaccination against human papillomavirus (HPV) is free and mandatory for 11-year-old girls, the death rate from cervical cancer is not declining in Argentina, and the geographical distribution of the burden is extremely unequal.”
In this post in the Guardian’s “Poverty Matters” blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, “NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development.” They continue, “In 2000, world leaders drafting the millennium development goals (MDGs) addressed many of the great development challenges, but they made one serious mistake: they omitted any mention of NCDs, which together cause nearly two out of three deaths in the world (80 percent of those in developing countries).”
“A new way to screen poor women for cervical cancer was introduced this month in El Salvador, using a test that was originally developed in China,” the New York Times reports. “The new test, called careHPV and made by Qiagen, a Dutch company, is a swab test for the DNA of the papillomaviruses that cause cancer,” the newspaper writes, noting a study published in the Lancet Oncology in 2008 found the test “was more than twice as sensitive” than the alternate method of “shining a light on the cervix and painting it with vinegar, which reveals precancerous lesions that can then be burned off with liquid nitrogen or carbon dioxide.” According to the New York Times, “The test worked even when women inserted the swabs themselves, which can be done at home and so is easier and faster than having them go to a clinic for visual inspections” (McNeil, 9/24).
“Some academics and non-profit organizations are skeptical of the motives of the increasing number of multinational companies who seek partnerships to address non-communicable diseases (NCDs),” Derek Yach, senior vice president of global health and agriculture policy at PepsiCo and former head of NCDs at WHO, writes in the Huffington Post’s “Impact” blog. He asks, “So how well is the private sector doing in tackling the rising pandemic of NCDs, which cause nearly two out of every three deaths in the world (80 percent of those in developing countries), the four main ones being cancer, cardiovascular disease, chronic respiratory disease and diabetes?” He continues, “The private sector is a major stakeholder in many ways — as employers; makers of food and medicines, sports gear and technology; as corporate citizens and consumers — and wants to be engaged in the global NCD dialogue. We deserve a seat at the table.”